mitochondrial dysfunction

HOUSTON, Texas, June 5, 2026 Eos SENOLYTIX, Inc. presented new preclinical findings for its lead MitoXcel™ geropeptide candidate PTC-2105...

GRAND RAPIDS, Mich., June 1, 2026 Cirius Therapeutics has announced the presentation of new clinical data supporting CIR-0602K, its...

NIJMEGEN, The Netherlands, May 19, 2026 Khondrion announced that the first patient has been dosed in the Phase II...